Rep. Barton oversight subcommittee to review OTC tests for illicit drugs at Sept. 26 hearing.
This article was originally published in The Tan Sheet
Executive Summary
REP. BARTON OVERSIGHT SUBCOMMITTEE TO REVIEW OTC TESTS FOR ILLICIT DRUGS at a hearing slated for Sept. 26. The hearing before Rep. Joe Barton's (R-Tex.) House Commerce/Oversight Subcommittee is expected to focus on parents' access to drugs-of-abuse testing technology, and likely will address FDA's moves to regulate an over-the-counter drug testing service in 1995.